Clinical Trial Update: Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether online adaptive stereotactic radiotherapy can eliminate planning target volume (PTV) margins in early-stage non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pulmonary Oligometastases

Snippet

Sponsor: Sun Yat-sen University | Conditions: Adaptive Radiotherapy, Stereotactic Body Radiotherapy | Phase 2 | Status: RECRUITING